2021
DOI: 10.1128/spectrum.00192-21
|View full text |Cite
|
Sign up to set email alerts
|

Combined Treatment of 6-Gingerol Analog and Tobramycin for Inhibiting Pseudomonas aeruginosa Infections

Abstract: Pseudomonas aeruginosa is a pathogen that causes various infectious diseases through quorum-sensing regulation. Although antibiotics are mainly used to treat P. aeruginosa infections, they cause the emergence of resistant bacteria in humans.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 55 publications
0
8
0
Order By: Relevance
“…Many scholars attempted to develop and use non-traditional antibacterial drugs, such as antimicrobial peptides, bacteriophages, and plant extracts that had certain antibacterial and virulence and biofilm inhibition effects, in place of traditional antibacterial drugs ( Khan et al, 2021 ; Witherell et al, 2021 ). The QSIs can decrease the strain virulence factors, biofilm formation ability of the strain; therefore, they proved to be ideal for treatment purposes ( Ham et al, 2021 ). Substances such as quercetin, resveratrol, and 6-gingerol ( Quecan et al, 2019 ; Ham et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Many scholars attempted to develop and use non-traditional antibacterial drugs, such as antimicrobial peptides, bacteriophages, and plant extracts that had certain antibacterial and virulence and biofilm inhibition effects, in place of traditional antibacterial drugs ( Khan et al, 2021 ; Witherell et al, 2021 ). The QSIs can decrease the strain virulence factors, biofilm formation ability of the strain; therefore, they proved to be ideal for treatment purposes ( Ham et al, 2021 ). Substances such as quercetin, resveratrol, and 6-gingerol ( Quecan et al, 2019 ; Ham et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, QSIs can act as synergists in delaying antimicrobial resistance development. The combination of QSIs and antibacterial drugs can restore bacterial sensitivity to previously tolerated drugs, thus helping reduce the effective dose and improve the efficiency of antibacterial drugs ( Ham et al, 2021 ). Natural QSIs mainly exist in bacteria, fungi, animals, and plants, and marine organisms ( Kalia, 2013 ).…”
Section: Introductionmentioning
confidence: 99%
“…Recently, 6-gingerol has been reported to be an excellent addition to isoniazid for the treatment of tuberculosis due to its potent antimycobacterial and immunomodulatory effects against Mycobacterium tuberculosis [ 107 ]. A combination of 6-gingerol and tobramycin was proved very effective against P. aeruginosa , and therefore, holds prospects for clinical applications for the treatment of P. aeruginosa infections [ 108 ]. In addition, 6-gingerol possesses antiviral effects, specifically against the Chikungunya virus, by inhibiting its replication [ 109 ].…”
Section: Notable Bioactivitiesmentioning
confidence: 99%
“…Moreover, compound 43 displayed strong inhibition of biofilm formation in static and dynamic settings and the reduction of virulence factor production (elastase, rhamnolipid, and pyocyanin) in P. aeruginosa . In addition, compound 43 did not cause toxicity to human lung epithelial cells and alleviated the infectivity of P. aeruginosa in Tenebrio molitor larvae [ 44 ].…”
Section: Rhlr-targeted Modulatorsmentioning
confidence: 99%